Skip to main content

Median Technologies: Financial Communications Schedule for the First Half of 2025

Regulatory News:

Median Technologies (FR0011049824, ALMDT, PEA-PME scheme eligible), announces the publication date for its 2024 results:

 

Publication

   

Date

 

2024 results

   

April 29, 2025*

*Distribution after the close of trading

About Median Technologies: Pioneering innovative imaging services and Software as Medical Devices, Median Technologies harnesses cutting-edge AI to enhance the accuracy of early cancer diagnoses and treatments. Median's offerings include iCRO, which provides medical image analysis and management in oncology trials, and eyonis™, an AI/ML tech-based suite of software as medical devices (SaMD). Median empowers biopharmaceutical entities and clinicians to advance patient care and expedite the development of novel therapies. The French-based company, with a presence in the U.S. and China, trades on the Euronext Growth market (ISIN: FR0011049824, ticker: ALMDT). Median is also eligible for the French SME equity savings plan scheme (PEA-PME). For more information, visit www.mediantechnologies.com.

Contacts

Recent Quotes

View More
Symbol Price Change (%)
AMZN  217.83
-4.20 (-1.89%)
AAPL  260.94
-1.83 (-0.70%)
AMD  236.55
-1.48 (-0.62%)
BAC  51.01
-0.52 (-1.00%)
GOOG  254.55
+3.21 (1.28%)
META  734.85
+1.58 (0.21%)
MSFT  522.00
+4.34 (0.84%)
NVDA  181.70
+0.54 (0.30%)
ORCL  274.95
-0.20 (-0.07%)
TSLA  438.51
-4.09 (-0.92%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.